Clinical Trials Directory

Trials / Completed

CompletedNCT01029717

CATCH - Catheter Infections in Children

A Randomised Controlled Trial Comparing the Effectiveness of Heparin Bonded or Antibiotic Impregnated Central Venous Catheters (CVCs) With Standard CVCs for the Prevention of Hospital Acquired Blood Stream Infection in Children

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
1,859 (actual)
Sponsor
Institute of Child Health · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Most children admitted to paediatric intensive care units (PICU) need to have medicines given to them into their veins using a narrow tube, so they do not need repeated injections. This tube is called a central venous catheter. Occasionally these catheters can cause infections in the blood and sometimes the tubes can get blocked by small blood clots. Some intensive care units already use antibiotic or heparin coated catheters, but there is no proof that these are better than the standard ones at preventing infections. Most of the PICU's in this country use standard lines. The only way to find out for certain is to compare children who are given antibiotic or heparin coated catheters with those who are given standard ones in a clinical trial. Because we do not know which type of catheter is best, the type of catheter each child receives in the study will be decided randomly by chance. Each child in the trial will have the same chance of getting any of these three catheters: * Standard central venous catheter (not coated). * Heparin coated central venous catheter. Heparin is a medicine that can stop blood from clotting and might stop the tubes being blocked and infections in the blood. * Antibiotic coated central venous catheter. Antibiotics can be used to kill bacteria which cause the infections. The aim of this study is to see how the three types of catheters compare in reducing the amount of blood infections in children. We will also look at the costs involved. We hope to recruit 1200 children in the UK over 2 years. We hope that the information we get from this study will guide policy about purchasing impregnated Central Venous Catheters across the NHS and thereby improve treatment for children in the future.

Conditions

Interventions

TypeNameDescription
DEVICEStandard polyurethane Central Venous CatheterStandard polyurethane Central Venous Catheter, All CVCs used in the trial are CE marked medical devices used for their intended purpose.
DEVICEAntibiotic impregnated polyurethane CVC (minocycline and rifampicin)Antibiotic impregnated polyurethane CVC (minocycline and rifampicin. All CVCs used in the trial are CE marked medical devices used for their intended purpose.
DEVICEHeparin bonded polyurethane CVCHeparin bonded polyurethane CVC. All CVCs used in the trial are CE marked medical devices used for their intended purpose.

Timeline

Start date
2010-12-01
Primary completion
2012-11-01
Completion
2012-11-01
First posted
2009-12-10
Last updated
2022-03-03

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01029717. Inclusion in this directory is not an endorsement.